AZD7762, a novel checkpoint kinase inhibitor, drives checkpoint abrogation and potentiates DNA-targeted therapies
AZD7762 是一种新型检查点激酶抑制剂,可促进检查点废除并增强 DNA 靶向疗法
期刊:Molecular Cancer Therapeutics
影响因子:5.3
doi:10.1158/1535-7163.MCT-08-0492
Sonya D Zabludoff, Chun Deng, Michael R Grondine, Adam M Sheehy, Susan Ashwell, Benjamin L Caleb, Stephen Green, Heather R Haye, Candice L Horn, James W Janetka, Dongfang Liu, Elizabeth Mouchet, Shannon Ready, Judith L Rosenthal, Christophe Queva, Gary K Schwartz, Karen J Taylor, Archie N Tse, Graem